Recent advances in analytical techniques have enabled the detection of drugs and drug metabolites in alternative biological specimens for the purposes of workplace testing. A wide variety of specimens are available, each providing valuable information concerning prior or current drug use. The present focus is on oral fluid (saliva), hair, and sweat. An extensive evaluation by the Division of Workplace Programs of the Department of Health and Human Services is underway to determine the utility of these specimens in federally regulated programs. In future years, the testing of alternative specimens will expand our ability to understand the patterns of drug use and will become routine in all areas of forensic toxicology.
Drug use in the workplace is a problem in the United States with a large number of illegal drug users employed in the workforce potentially posing a danger to themselves and others. Since the 1970s, urine drug testing has been the most common technique for detecting drug use in the workplace. Although widely utilized, problems such as the lack of longterm drug detection, the inability to correlate urine drug test results with drug impairment and blood drug concentrations, opiate source differentiation, specimen adulteration by donors, and privacy issues continue to affect the industry. Therefore, the testing of urine alone may not continue to guarantee a drug-free workplace. Focusing our attention on improving the comprehension of testing through broadening the scope of drug detection will lead to more effective drug-testing programs.
The selection of a specimen for drug analysis is influenced by a variety of factors, principally ease of specimen collection, analytical and testing considerations, and interpretation of results. Recently, interest has shifted from urine towards other specimens that can provide distinct advantages. These speci-mens include oral fluid (saliva), hair, and sweat (1) (2) (3) (4) (5) . Oral fluid was previously limited to aspects of therapeutic drug monitoring and insurance testing, but the introduction of several laboratory-based drug test systems and on-site devices have expanded drug testing capabilities. Hair testing was originally considered for metal detection and nutritional evaluation, but the development of specialized techniques for drug identification by immunoassay has increased its use. Sweat testing has come to the forefront through the introduction of a commercial sweat patch technology. The general relationship of a variety of specimens used in toxicology testing is shown in Figure 1 .
Although these techniques are available today and can be used wherever legally allowed, widespread acceptance and use require a comprehensive understanding and development of each of the specimen's relative merits. This evaluation has followed the principal example set in the past. The test for acceptance was whether the specimen would be accepted in the federally regulated workplace program. Urine testing was first introduced in 1987 and has been the mainstay since that time. In 1997, the Department of Health and Human Services (HHS) began evaluating alternative specimens for inclusion into its program to possibly complement and/or to substitute for urine. Urine was recognized as having many distinct advantages, but also suffers from some disadvantages. The use of other specimens may overcome some of the disadvantages of urine, but may themselves present issues of their own. Many of these are summarized in Table I . The Substance Abuse and Mental Health Services Administration's Division of Workplace Programs, through its Drug Testing Advisory Board, has been evaluating these specimens and has provided the public with several drafts of proposed mandatory guidelines (6) . During this evaluation process, the following fundamental issues were considered for each specimen type:
9 What drugs and drug metabolites are detected? 9 Are analytical methods available and sufficient? 9 What cutoff concentrations should be established? 9 Do the cutoff concentrations reflect a comparative time of drug use?
9 Can internal quality-control processes be designed to validate tests?
9 Can an effective external proficiency testing program be established?
9 What use is recommended for alternative specimens?
Workplace drug-testing programs are deterrent-based, hence the use of each specimen must be substantially equivalent to others for each type of use for the program to be effective.
The detection time of drugs and drug metabolites in oral fluid is relatively short, and analyte concentrations in the fluid are generally proportional to those found in plasma. It is possible with some drugs to correlate the concentration of analyte in the oral fluid with behavioral effects. Recent research suggests that the detection window for oral fluid is longer than previously expected when analytical sensitivity is increased, but the detection window for urine is shorter than previously reported, at least for tetrahydrocannabinol (THC). A number of devices are available for collecting oral fluid, hence cutoffs need to be established using the neat liquid. Both oral fluid and urine are amenable to testing at the point-of-collection, thus increasing their utility in roadside drug detection by law enforcement, parole/probation testing, and clinical assessments in occupational medicine clinics and hospital emergency room settings.
Hair analysis enables long-term detection of drug use. Unlike conventional specimens in which drugs and drug metabolites have a limited dwell time, hair provides a retrospective, longterm measure of drug that is directly related to the life span of the matrix. Differences in color and texture of hair may cause a variation in detection response. This, however, may not be substantially different than variations in drug detection in urine based on water content. Sweat provides a cumulative measure of drug use; however, it has limited applicability to the workplace. It is most appropriately applied to the monitoring of individuals in drug rehabilitation or in probation/parole programs because it provides a prospective, rather than retrospective, approach. Several commercial devices are available for the collection of sweat for drug analysis; however, the most common application is via the sweat patch.
In recent years, extraordinary advances in analytical techniques have enabled the detection of drugs and drug metabolites in alternative specimens. Although these technologies were considered immature and unsuitable for use in workplace drug testing just a few years ago, the field has grown, significantly increasing the body of scientific literature. Although the initial research in the area of alternative specimens utilized radioimmunoassay, newer non-isotopic commercial immunoassays are now widely available for screening of drugs and drug metabolites. Techniques such as the enzyme linked immunosorbent immunoassay (ELISA) have been adapted for detection of analytes in extracts/digests of hair, oral fluid, and sweat patches. The ELISA technique is semiquantitative, costeffective, highly sensitive, and amenable to automation. Many ELISA assays are especially applicable to alternative specimens because of their increased specificity to parent drug, rather than drug metabolite. Confirmation of presumptive positive test results require very sensitive and specific methodology. The majority of laboratories currently utilize gas chromatography-mass spectrometry (GC-MS) for the confirmation and quantitation of drugs and drug metabolites in oral fluid, hair, and sweat. However, many of the more challenging assays (e.g., cannabinoids) require MS-MS technology to achieve the required limits of detection. The past few years have also seen the introduction of liquid chromatography-mass spectrometry (LC-MS) in many of these laboratories. Adding these stateof-the-art techniques to the forensic workplace laboratory will facilitate the use of alternative specimens.
The physiological distribution of drugs in the human body suggests a varying relationship among drugs to be found in different specimens. Workplace programs focus on five classes of drugs of abuse, including marijuana/metabolites, cocaine/ metabolites, opiates/metabolites, phencyclidine, and amphetamines. The analytes recommended for workplace testing are shown in Table II . Specific cutoff concentrations were published in the HHS Draft 3 (6), but continue to evolve. Two factors dictate what they finally should be: first, the ability of each to perform satisfactorily in external proficiency testing programs, and second, the relation of the cutoff concentrations to the detection of similar populations of drug abusers. This will be fundamental for effective drug deterrence. Table II reflects the proposed analytes for the various specimens. In view of the increasing amphetamine-class drug problems, methylenedioxymethamphetamine (MDMA), methylenedioxyamphetamine (MDA), and methylenedioxyethylamphetamine (MDEA) have been added. Consideration must be given to the ability of amphetamine assays to detect MDMA, MDA, and MDEA, the requirement for amphetamine to be present in methamphetamine-positive cases, cocaine-to-benzoylecgonine ratios in selected specimens, and the testing of 6-acetylmorphine independent of the general opiate assay. Much discussion has centered around the recommended use of alternative specimens. Although the various drafts of the HHS guidelines have changed positions on this, we offer recommended uses in Table III . It is important that the specimens used for a given purpose be substantially equivalent. This is because economy would suggest that individual programs should be able to use the same specimens for the principal compo- Return-to-duty/Follow-up nents of the program which include pre-employment and random testing. Urine and oral fluid are suggested to be used for all purposes, whereas hair is limited to pre-employment and random, and sweat is limited to return-to-duty/follow-up. Hair may be useful for return-to-duty/follow-up if it had been used previously and been demonstrated to be negative in the same individual. The quantity of each specimen collected needs to be sufficient for initial testing, confirmatory testing, and split specimen preparation. In summary, oral fluid, hair, and sweat appear to sufficiently meet the requirements to be added to workplace drug testing, particularly laboratory-based programs. There are adequate analytical methods, and the relevant drugs and metabolites have been identified. Internal quality control is readily accomplished. External proficiency testing is being developed and has suggested the cutoff concentrations. What remains is to correlate cutoff concentrations for the various specimens to the incidence of drug detection in similar populations. Thus, the final formulation of multispecimen testing in deterrencebased drug testing programs will become reality.
